Does biotech prepare you for the presidency? Who really wants to gut the FDA? An...
The recent approvals signal a swifter turnaround for Regeneron than what analyst...
In a significant stride toward safeguarding the health of newborns, the Food and...
The Serra Pamies facility located in Reus, Spain, has had its manufacturing oper...
Due to issues that arose with the CRO responsible for developing Pfizer’s Lyme d...
Japan has granted a new drug substance patent for BioArctic’s monoclonal antibod...
Dizal has received approval from China’s NMPA for sunvozertinib to treat adult p...
The newly-launched business, called Corvardis, is already targeting the Humira b...
Candidates at the first Republican primary debate diverged on the extent of abor...
The EMA accepted Novaliq’s marketing authorisation application for cyclosporine ...
The companies received a $3.67m grant to develop a low-cost, temperature-stable ...
The diabetic macular oedema (DMO) market is expected to grow at a 6.0% CAGR over...
As the UK economy slowly recovers, the life sciences sector is seeking candidate...
XNK Therapeutics adds another research partner to evaluate XNK’s natural killer ...
FORE Biotherapeutics has raised $75m in its Series D investment round led by SR ...
“We estimated that there were approximately 10 million people in the first year ...
